about
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients.Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Buprenorphine Treatment for Probationers and Parolees.
@ast
Buprenorphine Treatment for Probationers and Parolees.
@en
Buprenorphine Treatment for Probationers and Parolees.
@nl
type
label
Buprenorphine Treatment for Probationers and Parolees.
@ast
Buprenorphine Treatment for Probationers and Parolees.
@en
Buprenorphine Treatment for Probationers and Parolees.
@nl
prefLabel
Buprenorphine Treatment for Probationers and Parolees.
@ast
Buprenorphine Treatment for Probationers and Parolees.
@en
Buprenorphine Treatment for Probationers and Parolees.
@nl
P2093
P2860
P1433
P1476
Buprenorphine Treatment for Probationers and Parolees.
@en
P2093
Frank J Vocci
Hamin Shabazz
Kathryn A Couvillion
Kevin E O'Grady
Laura J Sudec
Michael S Gordon
Robert P Schwartz
Timothy W Kinlock
P2860
P304
P356
10.1080/08897077.2014.902787
P577
2014-04-04T00:00:00Z